News, Analysis & Insights on Nutrition, Supplements, and Health
Industry is divided in its reaction to the recent rejection of glucosamine and joint health claims by the European Food Safety Authority (EFSA), with one manufacturer advocating a medical licensing route as an alternative way of securing claims.
New Jersey-based botanicals specialist, Sabinsa, has thrown its weight behind a citizen’s petition lodged by Canadian firm, Ovos Natural Health, that seeks to have its brain health ingredient recognized as dietary supplement ingredient after it initially...
Monsanto and Solae have received GRAS notification from the FDA for their soybean omega-3 but the product is unlikely to hit food shelves until the early part of the next decade.
The anti-prostate cancer effects of pomegranate and its extracts may be related to stopping an enzyme in the liver which processes environmental carcinogens, says a new study.
Pooling nutrient information is becoming an important and time efficient way for companies seeking scientific data about nutrients – especially those seeking to back health claims under the European Union’s tough claims system.
Supplements of the sunshine vitamin may improve insulin resistance and sensitivity, both of which are risk factors for diabetes, says a new study from New Zealand.
Sanofi-Aventis has signed a joint venture agreement with Minsheng Pharmaceutical Group of Hangzhou to exploit the country’s booming OTC vitamin and mineral market.
The US dietary supplements industry should make itself the master of change not its victim, according to Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).